Home › Peanut Hypersensitivity › Arkansas
Peanut Hypersensitivity clinical trials in Arkansas
6 studies for Peanut Hypersensitivity are looking for participants at sites in Arkansas.
Cities in Arkansas
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Arkansas Childrens Hosp Rsch Inst, Little Rock
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Arkansas Children's Hospital and Research Institute, Little Rock
RecruitingPhase 1Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Arkansas Children's, Little Rock
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811Safety of MOON101 for the Treatment of Peanut Allergy
- Arkansas Children's Research Institute, Little Rock
RecruitingPhase 1
Ages 4 to 55 · All sexes · Updated Jul 14, 2026 · NCT07580898From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.